The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: A systematic review and meta-analysis by Nuckols, TK et al.
Nuckols et al. Systematic Reviews 2014, 3:56
http://www.systematicreviewsjournal.com/content/3/1/56RESEARCH Open AccessThe effectiveness of computerized order entry at
reducing preventable adverse drug events and
medication errors in hospital settings: a systematic
review and meta-analysis
Teryl K Nuckols1,2*, Crystal Smith-Spangler3,4, Sally C Morton5, Steven M Asch3,4,2, Vaspaan M Patel6,7,
Laura J Anderson7, Emily L Deichsel7 and Paul G Shekelle1,2,8Abstract
Background: The Health Information Technology for Economic and Clinical Health (HITECH) Act subsidizes
implementation by hospitals of electronic health records with computerized provider order entry (CPOE), which
may reduce patient injuries caused by medication errors (preventable adverse drug events, pADEs). Effects on
pADEs have not been rigorously quantified, and effects on medication errors have been variable. The objectives of
this analysis were to assess the effectiveness of CPOE at reducing pADEs in hospital-related settings, and examine
reasons for heterogeneous effects on medication errors.
Methods: Articles were identified using MEDLINE, Cochrane Library, Econlit, web-based databases, and bibliographies
of previous systematic reviews (September 2013). Eligible studies compared CPOE with paper-order entry in acute care
hospitals, and examined diverse pADEs or medication errors. Studies on children or with limited event-detection
methods were excluded. Two investigators extracted data on events and factors potentially associated with
effectiveness. We used random effects models to pool data.
Results: Sixteen studies addressing medication errors met pooling criteria; six also addressed pADEs. Thirteen studies
used pre-post designs. Compared with paper-order entry, CPOE was associated with half as many pADEs (pooled risk
ratio (RR) = 0.47, 95% CI 0.31 to 0.71) and medication errors (RR = 0.46, 95% CI 0.35 to 0.60). Regarding reasons for
heterogeneous effects on medication errors, five intervention factors and two contextual factors were sufficiently
reported to support subgroup analyses or meta-regression. Differences between commercial versus homegrown
systems, presence and sophistication of clinical decision support, hospital-wide versus limited implementation, and US
versus non-US studies were not significant, nor was timing of publication. Higher baseline rates of medication errors
predicted greater reductions (P < 0.001). Other context and implementation variables were seldom reported.
Conclusions: In hospital-related settings, implementing CPOE is associated with a greater than 50% decline in pADEs,
although the studies used weak designs. Decreases in medication errors are similar and robust to variations in important
aspects of intervention design and context. This suggests that CPOE implementation, as subsidized under the HITECH Act,
may benefit public health. More detailed reporting of the context and process of implementation could shed light on
factors associated with greater effectiveness.
Keywords: Medical order entry systems, Drug toxicity/prevention and control, Hospitals, Adverse drug event,
Medication error* Correspondence: tnuckols@mednet.ucla.edu
1Division of General Internal Medicine and Health Services Research, David
Geffen School of Medicine at the University of California, 911 Broxton Ave,
Los Angeles, CA 90024, USA
2RAND Corporation, 1776 Main Street, Santa Monica, CA 90407, USA
Full list of author information is available at the end of the article
© 2014 Nuckols et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Nuckols et al. Systematic Reviews 2014, 3:56 Page 2 of 12
http://www.systematicreviewsjournal.com/content/3/1/56Background
The Health Information Technology for Economic and
Clinical Health (HITECH) Act of 2009 incentivizes the
adoption of health information technology by US hospitals.
This Act, part of the American Reinvestment and Recovery
Act, allocates up to $29 billion over 10 years for the imple-
mentation and 'meaningful use' of electronic health records
by hospitals and healthcare providers [1]. Hospitals that sat-
isfy meaningful use criteria can receive millions of dollars.
Implementing computerized provider order entry (CPOE)
with clinical decision support systems (CDSS) that check
for allergies and drug-drug interactions is one of several
basic (Stage 1) criteria for meaningful use by hospitals [2].
As of 2008, approximately 9% of general acute care hospi-
tals had at least basic electronic health record (EHR) sys-
tems including CPOE for medications. By 2012, 44% had
such systems, specifically, 38% of small, 47% of medium,
and 62% of large hospitals [3]. Thus, despite the financial
incentives, about half of small and medium hospitals and
almost 40% of large hospitals had not adopted CPOE with
CDSS in the most recent survey.
The primary potential benefit of adopting CPOE is redu-
cing patient injuries caused by medication errors, called
preventable adverse drug events (pADEs) [4-6]. Counter-
balancing this is concern about unintended adverse conse-
quences [7-9], including increases in medication errors
and even mortality, which have been detected in some
hospitals after implementation of CPOE [10,11]. To date,
no systematic review has examined net effects on pADEs,
the primary outcome of interest for this intervention. Pre-
vious reviews have, instead, focused almost exclusively on
an intermediate outcome, medication errors. However, not
all medication errors pose an equal risk of causing injury.
Errors in timing, for example, are generally less risky than
giving a medication to the wrong patient. Many commonly
used medications, such as anti-hypertensives and antibiotics,
have sufficiently long half-lives that receiving a dose an hour
or two late has little clinical effect. By contrast, receiving an
anti-hypertensive or antibiotic intended for someone else
poses risks of low blood pressure or an allergic reaction. In
one study at six hospitals, only about 20% of medication er-
rors led to pADEs [12]. Thus, the effect of CPOE on the pa-
tient outcome of pADEs is an important clinical and policy
question that has remained unanswered, until now.
In addition to focusing on medication errors rather than
pADEs, previous systematic reviews have reached conflicting
conclusions about the effects of CPOE on medication errors
in acute care settings. Some have concluded that CPOE re-
duces errors, whereas others argue that net effects remain
uncertain [4,5,13-42]. This controversy stems, in part, from
the fact that the association between CPOE implementation
and medication errors has exhibited substantial heterogen-
eity across primary studies [37]. Three basic types of factors
could explain such variability: intervention factors, such asdifferences in how the intervention is designed and imple-
mented; contextual factors, such as differences in patient
populations and settings; and methodological factors, such
as differences in study design and execution [43].
Uncertainty about the effects of CPOE on patient out-
comes and its variable effects on medication errors may
contribute to the reluctance of some hospitals and physi-
cians to adopt CPOE, despite the financial incentives avail-
able via HITECH. Consequently, our primary objective in
this study was to quantitatively assess the effectiveness of
CPOE at reducing pADEs in hospital-related acute care set-
tings. Our secondary objective was to identify factors con-
tributing to variability in effectiveness at reducing medication
errors. This analysis is timely as several studies have been
published recently and, therefore, were not included in previ-
ous reviews and meta-analyses [4,13,34,37,41], enabling us to
examine effects on pADEs and reasons for heterogeneity.
Methods
We adhered to recommendations in the Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses
(PRISMA) Statement [44,45], including developing the
protocol before undertaking the analysis.
Data sources and searches
First, we developed search strategies for eight databases:
MEDLINE; Cochrane Library; Econlit; Campbell Collab-
oration; the Agency for Healthcare Research and Quality
(AHRQ) Health Information Technology Library, Health
Information Technology Bibliography, Health Informa-
tion Technology Costs and Benefits Database Project,
and PSNET; Information Service Center for Reviews and
Dissemination at the University of York; Evidence for Policy
and Practice Information and Coordinating Centre (EPPI-
Centre), University of London; Oregon Health Sciences
Searchable CPOE Bibliography; and Health Systems
Evidence, McMaster University. A number of search
terms, such as 'order entry' and 'electronic prescribing'
(see Additional file 1), were chosen and strategies de-
veloped, in part based on a search strategy published
by Eslami et al. [4].
We used this strategy to search the eight databases
for systematic reviews of CPOE or CDSS that might
contain potentially relevant primary studies (last updated
September 23, 2013) (Figure 1). Next, we used the same
strategy to search the eight databases for potentially rele-
vant primary studies that were published after two large
previous systematic reviews on CPOE (January 1, 2007
to September 23, 2013) [4,13]. In addition, we hand-
searched nine websites (AHRQ HIT Library, AHRQ
PSNET, National Patient Safety Foundation, Joint
Commission, Leapfrog Group, Micromedex, Institute
for Healthcare Improvement), the Web of Science, and
bibliographies of other publications known to us.
Figure 1 Summary of evidence search and selection.
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We included peer-reviewed studies, regardless of lan-
guage or design, if they compared CPOE with paper-
order entry and examined either of our two primary
outcomes, rates of pADEs or medication errors, across
a variety of clinical conditions. Eligible settings included
adult medical or surgical wards, adult medical or surgi-
cal intensive care units (ICUs), emergency depart-
ments, or the entire hospital. To reduce unwarranted
variability due to contextual and methodological factors,
we excluded studies that were from non-hospital settings;
that addressed events limited to specific conditions (for ex-
ample, infections) or types of errors (for example, allergy
alerts); or that compared events in highly dissimilar pa-
tient care units. As minimum criteria for study quality,
we excluded studies that did not describe methods for
detecting medication events, or that used incident
reporting alone, which detects 0.2–-6% of events [46].
We also excluded pediatric studies because includingthem would increase heterogeneity: children comprise
only 6% of hospitalized patients whereas ADEs dispro-
portionately affect older adults [12,47,48].
Two investigators independently screened the article
titles and then abstracts for eligibility. We obtained
full-text articles when either investigator found the ab-
stract (or title, if the abstract was unavailable) poten-
tially eligible. Disagreements about the eligibility of
full-text articles were resolved by consensus, with a
third investigator participating for ties.
Data extraction and quality assessment
We defined pADEs as injuries to patients due to
medication errors. Medication errors were defined as
errors in the process of prescribing, transcribing, dis-
pensing, or administration of a medication, which had
the potential to or actually did cause harm. To focus
on errors involving relatively higher risk, we excluded,
when reported, 'errors' described as having no or
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illegible orders, disallowed abbreviations, disallowed
drug names, and medications given at the wrong time
(see Additional file 1).
Two investigators independently extracted data from
each study using a standardized form (see Additional
file 1). Disagreements were resolved by consensus, with
a third investigator adjudicating ties. Extracted elements
included numbers of pADEs and medication errors meet-
ing study definitions, units of exposure to risk of pADEs
or medication errors (for example, number of orders, dis-
pensed doses, admissions, or patient days). When studies
reported rates or proportions rather than these elements,
variance could not be estimated, so the studies could not
be included in pooled effect calculations and thus we
qualitatively summarized their results instead.
From the studies included in the pooled analysis of
medication errors, we extracted several elements related
to intervention design and implementation, context, and
study methods. Elements related to intervention design in-
cluded: CPOE developer (homegrown versus commercial);
and presence or absence of CDSS, CDSS sophistication
(basic, moderate, or advanced; see Table 1 for definitions).
When information about the system developer and CDSS
were missing from the published article, we contacted the
original authors.
Elements related to implementation were based on
an AHRQ report addressing context-sensitive patient
safety practices, including CPOE. These included: fac-
tors influencing the decision to adopt, factors facilitating
implementation, and aspects of implementation described
in the studies, as well as timing, extent of implementation
(limited number of units versus hospital-wide), and
whether use was mandatory (see Additional file 1 for de-
tails) [72].
Contextual elements included setting/population (type
of clinical unit within the hospital, academic status, public
versus private hospital, hospital size, country, primary lan-
guage in country, payer mix), and baseline proportion of
hospitalizations affected by medication errors.
Methodological elements included type of study design,
event detection methods, items related to study quality
(adapted from relevant reporting criteria in the Standards
for Quality Improvement Reporting Excellence; SQUIRE)
[73], and funding source.
Data synthesis and analysis
Using the DerSimonian–Laird random effects model [74],
we conducted meta-analyses for two outcomes (pADEs
and medication errors) for all eligible studies combined,
and for different subgroups of studies as described below.
For each eligible study and outcome measure, we calcu-
lated a risk ratio (RR) as the number of events per unit of
exposure in the CPOE group divided by events per unit ofexposure in the paper-order entry group. Units of expos-
ure varied across studies. If a study provided more than
one unit of exposure, we selected the unit most commonly
used in the included studies.
Within each meta-analysis, we tested the heterogeneity of
the log-transformed RRs using Q and I2 statistics [75]. Het-
erogeneity was present when the I2 statistic was 50% or
more and the P-value for the Q statistic was 0.05 or less.
We conducted two sensitivity analyses, removing one
study at a time from each meta-analysis to assess the in-
fluence of each individual study, and testing whether
the choice of units of exposure affected results. To assess
publication bias, we examined funnel plots, Begg and
Mazumdar’s rank correlation test, and Egger’s regression
intercept test [76].
Intervention design and implementation, contextual, and
methodological factors
A priori, we identified nine factors that might be associ-
ated with heterogeneity in medication errors across stud-
ies. Intervention design factors included type of CPOE
developer (homegrown versus commercial), presence or
absence of CDSS, and sophistication of CDSS (basic, mod-
erate, or advanced). Intervention implementation factors
included scope of implementation (hospital-wide versus
limited) and timing of CPOE implementation (year CPOE
was implemented or, if missing, the year the study was
published). Contextual factors included country (US ver-
sus non-US) and baseline proportion of hospitalizations
affected by medication errors. Methodological design fac-
tors included study design (pre-post versus other designs)
and event detection methods (pharmacist order review
versus more comprehensive methods). For each discrete
factor, we conducted a subgroup analysis when there were
at least three studies per subgroup, for example, pre/
post design versus other design. For each continuous
factor, we conducted a meta-regression using the factor as
the sole predictor. In each meta-regression, we pooled
log-transformed RRs, and presented the pooled results on
the original RR scale.
Pooled meta-analyses were conducted using Compre-
hensive Meta-analysis, V2 (Biostat, Englewood, NJ, USA);
meta-regression analyses were conducted in STATA (V13)
(StataCorp LP, College Station, TX, USA).
Results
We screened 4,891 potentially eligible records, including
the bibliographies of 32 systematic reviews on CPOE or
CDSS [4,5,13-42], and then examined 93 full-text articles
on CPOE. Of these 93 full-text articles, 74 were excluded:
32 did not test the effectiveness of CPOE, 3 addressed non-
hospital settings, 6 addressed pediatric settings, 5 used inci-
dent reporting alone to detect events, 1 did not describe
event detection methods, 16 addressed outcomes other
Table 1 Characteristics of included studies
Reference Country Number of
hospitals
(bed size)
Financial
status
Type of
hospital
Setting in
hospital
Baseline
error rate, %a
Developer of
CPOE system
Use of
CPOE
CDSSb Study
design
Event detection
methodsc
Bizovi et al.,
2002 [49]
USA 1 (560) Public Academic ED 3.6 (visits) Commercial
(EmSTAT;
CyberPlus)
Mandatory Noned Pre/post Routine pharmacist
review of medication
orders
Franklin et al.,
2009 [50-52]
UK 1 (−) (Probably
public)
Academic General
surgery ward
64.9 Commercial
(ServeRx V.1:13;
MDG Medical)
Mandatory None Pre/post Routine pharmacist
review of medication
orders, medical record
review, and incident
reporting
Shawahna
et al., 2011 [53]
Pakistan 1 (1280) Public Academic 2 medical wards 83.8 Homegrown Mandatory None Pre/post Medical record
review (R)
Shulman et al.,
2005 [54]
UK 1 (−) Public Academic General ICU 41.1 Commercial
(QS 5.6 Clinical
Information
System; GE
Healthcare)
Not stated None Pre/post Routine pharmacist
review of medication
orders
Leung et al.,
2012 [11]
USA 6 (100 to
300 each)
– Community Hospital-wide 42.3 Commercial
(not stated)
Not stated Present Pre/post Medical record and
order review (B, R)
Wess et al.,
2007 [55], [56]
USA 2 (665
and 555)
Private Academic,
Community
General surgery,
Orthopedic/
neurosurgical units
– Commercial
(LastWord®; GE,
formerly IDX)
Mandatory
(n = 1) and
voluntary
(n = 1)
Present Pre/post Routine pharmacist
review of medication
orders, with changes
signed by MD
Taylor et al.,
2002 [57]e
USA 3 (1000
in total)
Private Academic Hospital-wide – Not stated Not stated Present Pre/post Quarterly review
of subset of
medication orders
Barron et al.,
2006 [58]
USA 1 (525) Private Academic Hospital-wide 10.4 Homegrown Mandatory Basic Pre/post Routine pharmacist
review of medication
orders
Bates et al.,
1998 [59]
USA 1 (726) Private Academic 2 medical and 2
surgical wards,
2 ICUs
4.9 Homegrown Mandatory Basic Pre/post Medical record
review and other
means (B, R)
Van Doormal
et al., 2009 [60]
The
Nether-lands
2 (1300
and 600)
– Academic 2 medical wards
at each hospital
99.9 Commercial
(Medicator®; iSoft),
Partly Homegrown
(Theriak®),
Mandatory Basic Pre/post Medical record
and order review
Westbrook
et al., 2012 [61]
Australia 2 (400
and 326)
– Academic 4 medical wards
at one hospital;
1 cardiology and 1
psychiatry unit at
the other hospital
99.7 Commercial (Millenium
Power Orders; Cerner
and MedChart; iSoft)
Exceptions
allowed
Basic Differences
in differences
Routine pharmacist
review of medication
orders (R)
Weant et al.,
2007 [62]e
USA 1 (489) Public Academic Neurosurgical ICU – Not stated Not stated Moderated Pre/post Routine pharmacist
review of medication
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Table 1 Characteristics of included studies (Continued)
orders, incident
reporting
Bates et al.,
1999 [63]
USA 1 (700) Private Academic 2 medical
wards and
1 ICU
47.3 Homegrown Mandatory Moderate Pre/post Medical record
and order review
plus other means
Colpaert et al.,
2006 [64]
Belgium 1 (−) – Academic 3 units within
a surgical ICU
98.0 Commercial
(Centricity Critical
Care Clinisoft; GE
Healthcare Europe)
Mandatory Moderate Comparison of
similar units
Routine pharmacist
review of medication
orders (B)
Mahoney et al.,
2007 [65]
USA 2 (247
and 719)
Private Academic Hospital-wide – Commercial
(Siemens Medical
Solutions CPOE;
Siemens Medical
Solutions Health
Services Corp)
Exceptions
allowed
Moderate Pre/post Routine pharmacist review
of medication orders, with
changes accepted by
MD; incident reporting
Oliven et al.,
2005 [66]
Israel 1 (450) Public Academic Pulmonary service 62.1 Homegrown Not stated Moderate Compare
similar units
Medical record
and order review
Igboechi et al.,
2003 [67]e
USA 1 (350) Private Community Hospital-wide – Commercial
(Ulticare System
Database; Per Se
Technologies
Mandatory Moderate Pre/post Routine pharmacist review
of medication orders
Aronsky et al.,
2007 [68,69]
USA 1 (658) Private Academic ED 99.8 (visits) Homegrown (WizOrder,
later commercial-ized
as Horizon Expert
Orders; McKesson)
Not stated Advancedd Pre/post Routine pharmacist review
of medication orders
Mendendez
et al., 2012 [70]
Spain 1 (200) – Academic Hospital-wide 5.0 Commercial
(Selene; Siemens)
Not stated Advanced d Pre/post Trigger tool medical
record review, incident
reporting, and other means
CDSS, Clinical Decision Support Systems; CPOE, computerized provider order entry; ED, emergency department; ICU, intensive care unit.
aPercentage of hospitalizations (or emergency department visits, where noted).
bNone = no clinical decision support system; basic = checks for drug-allergy and drug-drug interaction; moderate = basic plus at least one additional clinical decision support function; advanced =moderate plus additional
capabilities [71].
cT = paper described training of reviewers; B = paper described blinding of reviewers to baseline versus CPOE conditions; R = Paper described methods for assessing reviewer reliability. If none of symbols appear, these
were not described.
dInformation on CDSS obtained by contacting authors.
eOmitted from pooled effect calculations due to lack of data related to estimating variance.
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or cost), 5 addressed errors limited to specific conditions, 1
addressed specific types of errors, 2 (1 in French) addressed
errors that were excluded because they posed a lower risks
of harm, 1 (in Spanish) compared event rates in dissimilar
clinical units (obstetric and oncology), and 2 were dupli-
cate publications of articles meeting the selection criteria
(Figure 1; see Additional file 1, Additional file 2).
The remaining 19 original articles met the selection
criteria and addressed medication errors; 7 of these also
addressed pADEs (Table 1) [11,49,50,53-55,57-68,70]. Of
these 19 studies, 3 omitted the data needed to estimate
variance and, therefore, were excluded from pooled ef-
fect calculations, resulting in 16 eligible studies, includ-
ing 6 that addressed pADEs [57,62,67].
Of the 16 studies, half were based in the US, including
two in community hospitals [11,55]. Thirteen studies
used pre/post designs [11,49,50,53-55,58-60,63,65,68,70],
two compared similar units within a hospital during the
same time period [64,66], and one compared changes
over time between intervention and control units (differ-
ences in differences design) [61]. Definitions of medica-
tion errors and the methods used to detect them varied
across studies (see Additional file 1). Seven studies iden-
tified events using data from routine pharmacist review
of medication orders [49,54,55,58,61,64,68]. One study
provided information on reviewer training [11], three on
blinding of reviewers [11,59,64], and none on reliability.
The baseline percentage of hospitalizations affected by
medication errors ranged from 3.6% [49] to 99.9% [60].
Nine studies assessed commercially developed CPOE
systems [11,49,50,54,55,61,64,65,70], six evaluated home-
grown systems [53,58,59,63,66,68], and one examined both
[60]. No two studies assessed the same commercial sys-
tem. CDSS was present in twelve studies [11,55,58-61,
63-66,68,70], and absent in four [49,50,53,54]; we con-
tacted and obtained responses from authors for three of
the studies (Table 1).
For all but one study [58], most of the desired infor-
mation on implementation was missing (see Additional
file 1). Based on the information that was reported, ten
studies described the use of CPOE as mandatory at one
or more sites [49,50,53,55,58-61,63,64]. CPOE was im-
plemented hospital-wide in four studies [11,58,65,70],
in the emergency department in two studies [49,68],
and in a limited number of inpatient units in the rest.
Four studies were conducted in complex organizations
with facilities in multiple communities [55,59,63,65], an-
other study was in a large hospital with affiliated clinics
[49], and another was in community hospitals [11]. Past
experience with information technology was reported in
seven studies [49,50,55,58,59,63,65]. Three studies re-
ported that organizational leadership influenced the adop-
tion decision [55,58,65], and four stated that staff trainingand education facilitated implementation [53,54,58,66].
One study mentioned the role of staff time to learn CPOE,
a person to lead implementation, extensive project man-
agement, an implementation timeline, teamwork, and pa-
tient safety culture related to CPOE [58]. Another study
described the effects of having a responsible person, local
tailoring, and teamwork [65].
The three studies omitted from the pooled analysis due
to lack of variance estimates were similar to the included
studies. They were conducted in the US in medium to
large hospitals, including one in a community hospital.
One study evaluated a commercially developed system
[67]; the other two did not report the developer. Two
studies included CDSS [57,67]. All three used pre/post de-
signs, one detected events using pharmacist review of
medication orders [67], and none reported reviewer train-
ing, blinding, or reliability. These studies also did not re-
port implementation context or processes in detail [62,67],
except for one, which discussed financial considerations
and leadership [57].
Primary outcome: preventable adverse drug events
Of the 19 studies, 7 assessed pADEs [11,59,60,62-64,70].
For the six studies in the pooled analysis, RRs ranged from
0.17 to 0.81. Overall, CPOE was associated with about half
as many pADEs as paper-order entry (pooled RR = 0.47,
95% CI 0.31 to 0.71). Studies were heterogeneous (I2 =
69%) (Figure 2). Serial removal of each study did not sub-
stantially influence results (pooled RR range 0.40 to 0.58).
There was no evidence of publication bias using a funnel
plot, or Begg and Mazumdar’s test (see Additional file 1).
For one study excluded from the pooled analysis due to
lack of data on variance, we calculated an RR of 0.11 [62].
Secondary outcome: medication errors
All 19 studies meeting selection criteria assessed medica-
tion errors [11,49,50,53-55,57-68,70]. Across the 16 stud-
ies eligible for the pooled analysis, RRs ranged from 0.16
to 2.08. The pooled estimate showed that medication er-
rors were approximately half as common when providers
used CPOE than when they used paper-order entry
(pooled RR = 0.46, 95% CI 0.35 to 0.60). The studies were
highly heterogeneous (I2 = 99%) (Figure 3). Results were
robust to serial removal of each individual study (pooled
RR range 0.42 to 0.49), and to selection of an alternative
unit of exposure in the four studies where that was pos-
sible (pooled RR = 0.45, 95% CI 0.34 to 0.59). There was
no evidence of publication bias using a funnel plot, or
Begg and Mazumdar’s test (see Additional file 1).
Two studies included in the pooled analysis reported
increases in medication errors after the introduction of
CPOE, however, both also reported statistically signifi-
cant decreases in preventable adverse drug events
[11,70]. A third study, excluded due to lack of data on
Figure 2 Meta-analysis: relative risk of preventable adverse drug events using computerized provider order entry (CPOE) versus
paper-order entry in hospital acute care settings. Units of exposure: *1,000 patient days; †admissions.
Favors CPOE    Favors Paper
Risk Ratio, D-L, Random (95%-CI)
0.1 1 10
CPOE Paper
Study Errors, N Units, N Errors, N Units, N Weight
Bates 1998 54 11,235* 127 12,218 6.08 0.46 (0.34-0.64)
Bates 1999 50 1,878* 242 1,704 6.12 0.19 (0.14-0.25)
Bizovi 2002 11 1,594† 54 2,326 4.81 0.30 (0.16-0.57)
Oliven 2005 220 5,033* 617 4,969 6.50 0.35 (0.30-0.41)
Shulman 2005 117 2,429† 71 1,036 6.15 0.70 (0.52-0.94)
Barron 2006 77 240,096‡ 252 240,096 6.27 0.31 (0.24-0.39)
Colpaert 2006 35 1,286† 106 1,224 5.86 0.31 (0.21-0.46)
Aronsky 2007 73 2,567† 125 3,383 6.17 0.77 (0.58-1.03)
Mahoney 2007 2,319 1,390,789† 4,960 1,452,346 6.62 0.49 (0.47-0.51)
Wess 2007 57 13,105† 239 8,595 6.17 0.16 (0.12-0.21)
Franklin 2009 127 501* 135 438 6.30 0.88 (0.65-1.05)
van Doormal 2009 1,203 7,058† 3,971 7,106 6.61 0.31 (0.29-0.33)
Shawnha 2011 1,147 14,064† 3,008 13,328 6.61 0.36 (0.34-0.39)
Leung 2012 645 1,000§ 550 1,000 6.56 1.17 (1.04-1.31)
Menendez 2012 1,197 11,347§ 356 7,001 6.55 2.08 (1.84-2.34)
Westbrook 2012 1,029 629§ 4,270 1,053 6.61 0.40 (0.38-0.43)
Total Medication Errors:  8,361 (CPOE); 19,083 (Paper) Overall 0.46 (0.35-0.60)
Tests for Heterogeneity:  I298.8%; Q statistic p < 0.0001
Overall Effect: z = -5.62, p < 0.0001
Intervention Design and Implementation (I), Contextual (C), and Methodological (M) Factors
I:  Type of Developer Homegrown (6 studies) 0.37 (0.29-0.47)
Commercial (9 studies )0.56 (0.36-0.85)
I:  Clinical Decision Support—Any Absent (4 studies) 0.51 (0.31-0.87)
Present (12 studies) 0.44 (0.32-0.62)
I:  Clinical Decision Support—Sophistication Basic (4 studies) 0.40 (0.38-0.87)
Moderate or Advanced (6 studies) 0.51 (0.26-0.97)
I: Scope of Implementation Limited Number of Units (12 studies) 0.38 (0.32-0.46)
Hospital-wide (4 studies) 0.78 (0.36-1.70)
C:  Country U.S. (9 studies) 0.39 (0.27-0.57)
Non-U.S. (7 studies) 0.56 (0.35-0.89)
M: Event Detection Methods Pharmacist Order Review (7 studies) 0.38 (0.27-0.53)
More Comprehensive Methods (9 studies) 0.53 (0.36-0.79)
Figure 3 Meta-analysis: relative risk of medication errors using computerized provider order entry (CPOE) versus paper-order entry in
hospital acute care settings. Units of exposure: *1,000 patient days; †orders; ‡dispensed doses; §admissions.
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crease in pADEs, but statistical testing was not per-
formed [62].
For two studies excluded from the pooled analysis due
to lack of data on variance, we calculated RRs of 0.61
[67], and 1.73, respectively [62]. In the third such study,
the authors reported a 50% decline in medication errors
(see Additional file 1) [57].
Intervention design and implementation, contextual, and
methodological factors
Six of the a priori subgroup analyses met the requirement
to have at least three studies per subgroup and were,
therefore, conducted (two were on one variable, CDSS)
(Figure 3). Two univariate meta-regression analyses were
able to examine whether baseline medication error rate or
year of publication (a proxy for maturity of CPOE inter-
vention; date of implementation was frequently missing)
predicted effectiveness.
Of five intervention design and implementation factors
examined, none reached the conventional level of statis-
tical significance, including type of developer (commer-
cial 0.56 (95% CI 0.36 to 0.85) versus homegrown 0.37
(0.29 to 0.47)), type of CDSS (present 0.44 (0.32 to 0.62)
versus absent 0.51 (0.31 to 0.87), and basic 0.40 (0.38 to
0.87) versus moderate or advanced 0.51 (0.26 to 0.97)),
and scope of implementation (hospital-wide 0.78 (0.36
to 1.70) versus limited 0.38 (0.32 to 0.46)). Year of publi-
cation was not associated with differential effectiveness.
Two contextual factors were evaluated. Studies per-
formed in the US showed greater effectiveness than non-
US studies, but this difference was not statistically signifi-
cant. As the baseline percentage of hospitalizations associ-
ated with medication errors increased from 3.6% to 99.9%
(data available for 12 studies), the predicted RR of medica-
tion errors with CPOE decreased from 1.90 to 0.08 (P <
0.001).
Regarding methodological factors, studies that used
pharmacist order review reported greater effectiveness
than studies using more comprehensive event detection
methods, although this difference was not statistically
significant. Almost all studies used pre/post designs so
this subgroup analysis was not conducted.
Discussion
The principal finding of this analysis is that CPOE is as-
sociated with a significant reduction in pADEs (hat is,
the patient injuries it was designed to prevent) in adult
hospital-related acute care settings. Specifically, com-
pared with using paper orders, using CPOE was associ-
ated with about half as many pADEs. Medication errors,
likewise, were also about half as common with CPOE as
with paper-order entry, and the reduction was generally
similar across studies with different intervention designsand different implementation, contextual, and methodo-
logical characteristics. There were no statistically significant
differences in effect between commercial and homegrown
systems, with or without CDSS of differing sophistication
levels, and between hospital-wide or more limited imple-
mentations. The baseline rate of hospitalizations associated
with medication errors was significantly associated with ef-
fectiveness, as increasing baseline rates of errors were asso-
ciated with increasing effectiveness. This is expected,
because, with few errors, there can be little to change.
Our pooled analysis is conclusive that CPOE is associ-
ated with a reduction in pADEs. Shamliyan et al. exam-
ined ADEs that might or might not have been related to
medication errors, and, therefore, were not as likely to be
affected by CPOE. These authors observed significant de-
clines in only three of seven studies (including pediatric
ones), and did not perform a pooled analysis [37].
With regards to the overall pooled result for medication
errors, our findings are generally consistent with those of
earlier, more limited systematic reviews and meta-analyses
[34,37,41]. Radley and colleagues also found that medica-
tion error rates declined by about half with CPOE imple-
mentation (48%, 95% CI 41 to 55%), using a small set of
early studies [34]. Van Rosse and colleagues observed
greater effectiveness with CPOE than we did (RR of medi-
cation errors = 0.08, 95% CI 0.01 41 to 0.76), but examined
only three diverse studies [41]. Shamliyan and colleagues
found that CPOE was slightly more effective than we did
(odds ratio for medication errors = 0.34, 95% CI 0.22 41 to
0.52), based on inpatient and outpatient studies from be-
fore 2006 [37]. In comparison to these previous studies,
we were able to identify a greater number of relevant arti-
cles despite having more restrictive selection criteria (see
Additional file 1), enabling us to explore reasons for study
heterogeneity.
Also like previous reviews [37], we observed substantial
variability across studies in the effectiveness of CPOE at
reducing medication errors. It has long been suspected
that variability in the effectiveness of a complex sociotech-
nical intervention such as CPOE may be related not only
to intervention design but also to context and implemen-
tation factors [16,77,78]. However, across the intervention
design and implementation as well as contextual variables
that we assessed, we did not see any statistically significant
differences in the associations between CPOE use and re-
ductions in medication errors. Two studies of commercial
CPOE systems in hospital-wide implementations reported
increases in medication errors but reductions in pADEs
[11,70]. One potential explanation for these seemingly
contradictory results is that the CPOE systems may
have created new medication errors at lower risk for
causing ADEs (such as concurrent submission of dupli-
cate orders due to order sets) but reduced medication
errors at higher risk of causing ADEs (such as serious
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made errors easier to detect. The potential to create
new types of low-risk medication errors calls attention
to the importance of tailoring the CPOE system to the
local environment because such errors place a time bur-
den on providers.
This analysis has limitations. We relied on 32 previous
systematic reviews to detect primary studies published
before 2007. Because each review detected a slightly dif-
ferent set of publications (see Additional file 1), per-
forming our own search of that period would have been
unlikely to detect additional studies. We excluded
pediatric studies instead of examining population age as
a subgroup because these groups differ in their risk for
experiencing medication errors and pADEs. Future in-
vestigators could evaluate the feasibility of conducting a
similar meta-analysis for pediatric populations. We also ex-
cluded studies that relied upon incident reporting or did
not describe event detection methods, considering these to
be minimum criteria for study quality. The number of stud-
ies that examined pADEs was not large, but all studies de-
tected declines. Most studies were conducted in academic
centers, limiting generalizability to community hospitals.
Finally, the included studies all used limited methods, in-
cluding using pre/post designs and lacking robust data-
collection methods.
Conclusion
Implementing CPOE is associated with a greater than 50%
decline in pADE rates in hospital-related settings, although
results vary. Medication errors decline to a similar degree.
Changes in medication errors appear to be consistent
across commercial and homegrown systems, with or with-
out clinical decision support, and in individual units or
hospital-wide implementations. Many context and imple-
mentation variables have, unfortunately, not been reported
sufficiently to assess their association with effectiveness.
Overall, these findings suggest that the CPOE requirements
for meaningful use under the HITECH Act may benefit
public health. Knowledge about how to make CPOE more
effective would be greatly facilitated by greater reporting of
context and implementation details.Additional files
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